🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Leora Horn

Vanderbilt University

ORCID: 0000-0003-2070-2547

Also affiliated with AstraZeneca (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 6%percentile
0.310Author DataRank

Indexed papers

2in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

ERJ Open Research(2022)10.1183/23120541.00684-2021
Top 65%
0.201DataRank
Top 65%2 citations

Li‐Ching Huang, Jennifer G. Whisenant, Sally J. York, Travis Osterman, Jennifer A. Lewis +7 more

Papers

Driven by 11 papers — median percentile 31. Top paper: “New Approaches to SCLC Therapy: From the Laboratory to the Clinic”.

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.016
N/A
5.4DataRank · unranked
178 citations

Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +42 more

TERAVOLT: Thoracic Cancers International COVID-19 Collaboration

Cancer Cell(2020)10.1016/j.ccell.2020.05.008
N/A
0.614DataRank · unranked
59 citations

Annalisa Trama, Valter Torri, Alessandro De Toma, Giuseppe Viscardi, Alessio Cortellini +12 more

Circulating Tumor DNA as a Biomarker of Radiographic Tumor Burden in SCLC

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100110
N/A
0.425DataRank · unranked
16 citations

Aneri Balar, Dhairya A. Lakhani, Christien Kluwe, Zhiguo Zhao, Prasad Kopparapu +17 more

Evidence-based smoking cessation treatment: a comparison by healthcare system

BMC Health Services Research(2021)10.1186/s12913-020-06016-5
N/A
0.330DataRank · unranked
8 citations

Nicole Senft, Heidi Chen, Kathryn E. Weaver, Lucy B. Spalluto, Kim L. Sandler +6 more

Associations of influenza vaccination with severity of immune-related adverse events in patients with advanced thoracic cancers on immune checkpoint inhibitors

ERJ Open Research(2022)10.1183/23120541.00684-2021
Top 65%
0.201DataRank
Top 65%2 citations

Li‐Ching Huang, Jennifer G. Whisenant, Sally J. York, Travis Osterman, Jennifer A. Lewis +7 more

Disparities in outcomes between Black and White patients in North America with thoracic malignancies and COVID-19 infection (TERAVOLT)

Lung Cancer(2023)10.1016/j.lungcan.2023.107423
Top 72%
0.109DataRank
Top 72%1 citations

Chih–Yuan Hsu, Jennifer G. Whisenant, Melina E. Marmarelis, Carolyn J. Presley, Karen L. Reckamp +24 more

Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

UNC Libraries(2020)10.17615/74ry-7003
N/A
0DataRank · unranked
0 citations

Editta Baldini, Pierre-Jean Souquet, Grace K. Dy, Ariel López-Chávez, Federico Cappuzzo +25 more

Characterizing toxicities, body composition, and health-related quality of life (HRQoL) among long-term survivors treated with anti-PD-1.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.e15158
N/A
0DataRank · unranked
0 citations

Arissa Young, Henry T. Quach, Grant R. Williams, Fei Ye, Run Fan +8 more

Cox Proportional Hazard Ratios Overestimate Survival Benefit of Immune Checkpoint Inhibitors: Cox-TEL Adjustment and Meta-Analyses of Programmed Death-Ligand 1 Expression and Immune Checkpoint Inhibitor Survival Benefit

Journal of Thoracic Oncology(2022)10.1016/j.jtho.2022.08.010
N/A
0DataRank · unranked
1 citations

Chih–Yuan Hsu, Jeng-Fong Chiou, Lynne D. Berry, Leora Horn, Paul A. Bunn +5 more

Identification and Characterization of Avoidable Hospital Admissions in Patients With Lung Cancer

Journal of the National Comprehensive Cancer Network(2023)10.6004/jnccn.2023.7049
N/A
0DataRank · unranked
7 citations

Xuanyi Li, Li‐Ching Huang, Amanda S. Cass, Wade T. Iams, Emily A. Skotte +9 more

Blood-Based Surveillance Monitoring of Circulating Tumor DNA From Patients With SCLC Detects Disease Relapse and Predicts Death in Patients With Limited-Stage Disease

JTO Clinical and Research Reports(2020)10.1016/j.jtocrr.2020.100024
N/A
0DataRank · unranked
23 citations

Prasad Kopparapu, Yingjun Yan, Anel Muterspaugh, Zhiguo Zhao, Heidi Chen +13 more